All News about Nanoviricides IncFrom NanoViricides, Inc.
Via AccessWire
EXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile
September 21, 2021
Via Benzinga
Exposures
COVID-19
53 Biggest Movers From Yesterday
September 16, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact
September 14, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|